TNF and rheumatoid arthritis: In Mtb infection and treatment experiments aimed at ruling out these clinical concerns, dTBP2 decreased the severity of TB infection more than anti-TNF–α monoclonal antibody, which is used in RA treatment, and showed a phenotype similar to that of the vehicle-treated groups (Fig. 6a–d).